Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncocort in previously treated progressive Multiple Myeloma
NCT03033316Phase 2Terminated
- Sponsor
- Enceladus Pharmaceuticals
- Start
- Jan 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules, Lipid-based Nanoparticles
01
Overview
A Phase 2 trial of peg-liposomal dexamethasone sodium phosphate in multiple myeloma (MM), sponsored by Enceladus Pharmaceuticals. Started Jan 2017; status: terminated.
02
Drugs
peg-liposomal dexamethasone sodium phosphate
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03033316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033316.